期刊文献+

加味黄连温胆汤治疗H型高血压胰岛素抵抗的临床疗效观察 被引量:8

Clinical Observation of Modified Huanglian Wendan Decoction( 加味黄连温胆汤)in Treatment of Insulin Resistance in H - Type Hypertension
原文传递
导出
摘要 目的观察加味黄连温胆汤治疗H型高血压的血压、Hcy和胰岛素抵抗的临床疗效,探索其疗效其安全性。方法选取黑龙江中医药大学第一附属医院心内科门诊部符合H型高血压患者总计60例,随机分为对照组(n=30例)和治疗组(n=30例)。对照组予西药依那普利叶酸片治疗,治疗组在对照组的基础上予联合加味黄连温胆汤。治疗6周后观察两组血压、Hcy、HOMA-IR和中医症状等治疗前后变化。结果治疗前后两组血压均明显下降(P<0.01),且治疗组下降明显优于对照组(P<0.05)。血压总有效率治疗组高于对照组(P<0.05)。两组治疗前后空腹血糖、空腹胰岛素、Hcy和IR均降低(P<0.05),且疗后治疗组降低明显优于对照组(P<0.05)。治疗前后两组中医症状积分皆有所下降(P<0.05),而疗后治疗组下降程度明显高于对照组(P<0.01)。中医症状疗效总有效率比较,治疗组高于对照组(P<0.05),具有明显统计学意义。结论加味黄连温胆汤可明显降低血压、Hcy和胰岛素抵抗,显著改善中医临床症状。 Objective To observe the clinical efficacy of Modified Huanglian Wendan Decoction(加味黄连温胆汤)in the treatment of blood pressure,Hcy and insulin resistance in H-type hypertensionandexplore its efficacy and safety.Methods A total of 60 patients with H-type hypertension in the outpatient department of cardiology of The First Affiliated Hospital of Heilongjiang University of Chinese Medicine were randomly divided into the control group(n=30)and the treatment group(n=30).The control group was treated withEnalapril Folic Acid Tabletsand the treatment group was treated with Modified Huanglian Wendan Decoction on the basis of the control group.Blood pressure,Hcy,HOMA-IR and TCM symptoms of the two groups were observed after 6 weeks of treatment.Results The blood pressure of both groups was decreased significantlyafter treatment(P<0.01),and the decrease in the treatment group was significantly better than that in the control group(P<0.05).The total effective rate of blood pressure in the treatment group was higher than that in the control group(P<0.05).Fasting glucose,fasting insulin,Hcy and insulin resistance were all decreasedafter treatment in both groups(P<0.05),and the reduction in the treatment group was significantly better than that in the control group(P<0.05).Before and after treatment,the TCM symptom scores of both groups were decreased(P<0.05),while the degree of decrease in the treatment group was significantly higher than that in the control group(P<0.01).The total effective rate of TCM symptoms was higher in the treatment group than that in the control group,with significant statistical significance(P<0.05).Conclusion Modified Huanglian Wendan Decoction can significantly reduce blood pressure,Hcy and insulin resistance,and significantly improve the clinical symptoms of TCM.
作者 李秀婷 刘莉 LI Xiuting;LIU Li(Heilongjiang University of Chinese Medicine,Harbin 150040,Heilongjiang,China;The First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin 150040,Heilongjiang,China)
出处 《辽宁中医杂志》 CAS 2021年第7期131-133,共3页 Liaoning Journal of Traditional Chinese Medicine
基金 国家自然科学基金(81573935)
关键词 H型高血压 HCY 胰岛素抵抗 加味黄连温胆汤 H-type hypertension Hcy insulin resistance Modified Huanglian Wendan Decoction(加味黄连温胆汤)
  • 相关文献

参考文献4

二级参考文献67

  • 1加娜提,张向阳.高同型半胱氨酸血症致血管内皮功能障碍研究进展[J].心血管病学进展,2007,28(2):315-317. 被引量:11
  • 2McCully KS. Vascular pathology of homocysteine:impiications for the pathogenesis of arteriosclerosis [J].Am J Pathology, 1969(56):111-128.
  • 3McCully KS,Ragsdale BD. Production of arteriosclerosis by hamocysteinemia[J].Am J Pathology,1970(61): 1-11.
  • 4Bouskey CJ,Beresford SA,Omenn GS,et al.A quantitative assessment of plasma homocysteine as a risk factor for vascular disease[J].JAMA, 1995(274):1049- 1057.
  • 5Ueland PM,Refsum H,Stabler SP,et al. Total homocystein-einplasma of serum:Methods and clinical applications[J]. Clin Chem, 1993, 39 (9) : 1764.
  • 6EIKossi MM. Oxidative stress in the context of acute cerebrovascular stroke [J].Stroke,2000,31 (8):1889- 1892.
  • 7WooKS,Chook FP, Lolin YI,et al. hyperhomocystc-inemiaisa risk factor for arterial endothelial dysfunction in humans [J].Circulation, 1997,96(8):2542-2544.
  • 8EIKossi MM,Zakhary MM.Oxidative stress in the context of acureceredro vascular stroke [J].Stroke, 2000,31(8):1889-1892.
  • 9Malinow MR,Bostom hG,Krauss RM. Homocyst (e) ine,diet and cardiovascular diseases:a statement for healthcare professionals from the Nutrition Committee, American Heart Association [J].Circulation, 1999,99 82.
  • 10James F,Toole M. ReneMalinow, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke,Myocardial infarction and death[J].JAMA,2004,291(5):565.

共引文献138

同被引文献112

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部